PVMCV

Polaris Venture Management Co V Portfolio holdings

AUM $14.1M
1-Year Est. Return 121.41%
This Quarter Est. Return
1 Year Est. Return
+121.41%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$14.1M
AUM Growth
-$48.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

1
+$49.5M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LYRA icon
1
Lyra Therapeutics
LYRA
$11.3M
$10M 71.28%
22,017
XFOR icon
2
X4 Pharmaceuticals
XFOR
$66.7M
$1.65M 11.7%
10,383
ATYR
3
aTyr Pharma
ATYR
$99.9M
$1.19M 8.42%
130,572
DARE icon
4
Dare Bioscience
DARE
$27.4M
$545K 3.87%
27,187
GNCA
5
DELISTED
Genocea Biosciences, Inc.
GNCA
$379K 2.69%
197,345
PULM icon
6
Pulmatrix
PULM
$17.6M
$288K 2.04%
17,972
FATE icon
7
Fate Therapeutics
FATE
$170M
– –
-569,889